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Abstract
Background Diabetes is a chronic condition that can lead to devastating complications if not managed effectively.
Individuals with elevated HbA1c are at higher risk of developing complications resulting in diabetes-related hospital
admissions, an additional pressure and expense for healthcare systems.
Aim To systematically review evidence of the effectiveness of psychosocial interventions among individuals with
elevated HbA1c, as indicated by hospital admissions.
Methods Electronic databases (MEDLINE, PsychINFO, CINAHL, AMED, Embase and Scopus) were used to identify
studies systematically. Studies were screened against eligibility criteria and included if they evaluated the effectiveness of
a psychosocial intervention on diabetes-related hospital admissions in individuals with elevated HbA1c. Risk of bias was
assessed using the Effective Public Health Practice Project Quality Assessment Tool for Quantitative Studies, and a
narrative synthesis was conducted.
Results Of 15 362 studies, five were included in the review. Psychosocial interventions were found to significantly
reduce diabetes-related hospital admissions in four of these studies and interventions involving psychotherapy in
particular were found to reduce admissions. The methodological quality of studies ranged from weak to moderate, due
to lack of blinding, weak study design and issues with withdrawals and drop-outs.
Conclusions Psychosocial interventions may reduce diabetes-related hospital admissions in individuals with elevated
HbA1c; however, due to variability in methodological rigour, the conclusion remains tentative. Further research
targeting this group, particularly within the adult population, is recommended. (PROSPERO registration number:
CRD42019133456).
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Introduction
It is reported that the National Health Service (NHS) spends
at least £10bn per year on diabetes, with almost 80% of this
money spent on treating complications, many of which are
preventable [1]. When diabetes is uncontrolled, there are
increased healthcare costs resulting from costly complica-
tions such as diabetic ketoacidosis, heart disease, blindness
and kidney failure which are often preventable through
ongoing glycaemic control [2,3,4,5,6]. Ketoacidosis is a
frequent occurrence among people with diabetes who have
elevated HbA1c levels, particularly among adolescents with
type 1 diabetes, and is often preventable [7]. Such admissions
cost the NHS £2064 per adult treated and £1387 per
adolescent treated [8,9]. Reducing ketoacidosis admissions as
well as other diabetes-related complications will significantly
reduce NHS costs. Since the risk of hospitalisation for
individuals with diabetes is almost twice that of others
[10,11] it is important to understand which interventions are
effective among people with diabetes and elevated HbA1c,
with the goal of reducing admissions.
HbA1c levels provide a good indication of glycaemic
control, with levels of 53 mmol/mol (7.0%) or below
indicating good glycaemic control with risk of complications
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at a similar level to that of the general population, and levels
of 58 mmol/mol (7.5%) and above indicating substantial risk
of complications and the need for further intervention [12].
Crucially, individuals with elevated HbA1c are more likely to
have higher utilisation of healthcare services, resulting in
additional costs for the healthcare system [13].
Elevated HbA1c is likely to stem from a wide range of
psychosocial factors, and the interventions examined in the
present review are therefore limited to this category.
Although diabetes is a physiological disease with effective
medication available, management is largely behavioural
[14]. It is well recognized that environmental, social,
behavioural and emotional factors, known as psychosocial
factors, play a key role in determining management outcomes
in individuals with diabetes [6,15]. Psychosocial difficulties
impact an individual’s ability to undertake the extensive
behavioural demands required to effectively manage diabetes,
and it is estimated that up to a third of those living with
diabetes experience such difficulties [16,17,18,19,20]. As a
result of these difficulties, many individuals with diabetes do
not achieve optimal blood glucose control even with an
effective medication regime in place.
Many individuals living with diabetes experience diabetes
distress, as a result of becoming overwhelmed by the demands
ofdiabetes.High levels of diabetes-relateddistress are linked to
elevated HbA1c and a decline in self-management as individ-
uals experience ‘diabetes burnout’, increasing the risk of
diabetes-related complications and hospital admissions [21].
This is also foundwith othermental health problems including
anxiety and depression, and there is consistent evidence that
diabetic ketoacidosis presentations are associated with psy-
chological difficulties [16,22]. Such psychological comorbidi-
ties interfere with the person’s ability to carry out diabetes self-
management and are associated with reduced adherence to
treatment and increased risk of diabetes complications [23].
It is widely recognised that psychosocial care should be
integrated with a collaborative approach to optimise health
outcomes and health-related quality of life [24]. Lack of
adequate psychosocial support is shown to have a negative
effect on various outcomes, including blood glucose control,
thuspsychosocial support is an integral partofdiabetes careand
should be accessible to individuals living with diabetes [25,26].
Psychosocial interventions are associated with a reduction in
psychological and diabetes-relateddistress, improvedquality of
life and reported self-management in individuals with diabetes
[27,28,29]. There is also evidence that psychosocial interven-
tions are effective at improving glycaemic control and reducing
outpatient appointments and emergency inpatient admissions,
leading to a significant reduction in healthcare costs [30,31,32].
Psychosocial interventions are diverse, integrating psycholog-
ical, behavioural and environmental aspects of diabetes to
improve mental health outcomes associated with the diagnosis
and management of diabetes alongside the lifestyle and
behaviour changes required.
To develop effective interventions for individuals with
elevated HbA1c, we need to understand what works. To date,
the literature has focused on the psychological impact of
diabetes, with the majority of existing systematic reviews
exploring the impact of psychosocial interventions on depres-
sive symptoms, diabetes-related distress and quality of life in
people living with diabetes [33,34,35]. Whilst some reviews
have explored the impact of psychosocial interventions on
general diabetes management and physical health outcomes
[36,37,38], the impact of diabetes on healthcare utilisation
and what interventions are effective to reduce utilisation and
pressure on services has been overlooked. Therefore, the
present reviewwill address the current gap in the literature and
exclusively focus on hospital admission reduction.
The aim of the review was to identify all eligible psychoso-
cial interventions targeted at reducing diabetes-related hospi-
tal admissions among individuals with elevated HbA1c
(defined as individuals with an HbA1c level of >58 mmol/
mol (7.5%). This adds to the current literature on the impact
of interventions on diabetes self-management and addresses a
gap in the literature by looking at interventions targeted at
individuals with elevated HbA1c and their effectiveness with
regard to diabetes-related hospital admissions. Whilst there is
no universal consensus within the literature to identify an
HbA1c threshold indicating uncontrolled diabetes, for the
purposes of this review, the level of 58 mmol/mol (7.5%) and
above was used to define elevated HbA1c, as previously stated
by National Institute for Health and Care Excellence (NICE;
2015) and Buckinghamshire Healthcare NHS Trust (2017).
Method
Protocol and registration
This study was conducted according to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
What’s new?
• People with diabetes and elevated HbA1c concentra-
tions are more likely to develop complications resulting
in hospital admissions. Psychosocial factors play a key
role in determining self-management outcomes, and
psychosocial interventions are shown to improve psy-
chological well-being and physical health outcomes.
• This review found that psychosocial interventions, in
particular psychotherapy, may reduce hospital admis-
sions among individuals with diabetes who have
elevated HbA1c.
• Results indicate that designing and testing psychosocial
interventions targeting individuals with elevated HbA1c
has the potential to improve psychological well-being
and therefore reduce preventable hospital admissions
and associated costs among this population.
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(PRISMA) guidelines [39]. A protocol for this systematic
review was published and can be accessed on PROSPERO
(CRD42019133456; available at: https://www.crd.york.ac.
uk/prospero/display_record.php?ID=CRD42019133456).
Eligibility criteria
Articles meeting the following eligibility criteria were
included:
1. Studies published in the English language in a peer-
reviewed journal with a quantitative methodology. No
limitations were applied to year of publication to identify
as many potentially eligible studies as possible.
2. Studies that included a psychosocial intervention aimed at
improving outcomes in people with diabetes were
included. Psychosocial interventions were defined as any
intervention emphasising psychological or social factors as
opposed to biological factors [40]. Interventions targeting
multiple chronic conditions were excluded as the focus of
the review was to identify interventions targeting individ-
uals with elevated HbA1c levels specifically.
3. Studies evaluating the effectiveness of the intervention on
individuals diagnosed with either type 1 or type 2 diabetes
with elevated HbA1c were included. In this review elevated
levels were defined as an HbA1c level of >58 mmol/mol
(7.5%) as individuals diagnosed with diabetes are recom-
mended to control HbA1c levels between 48 and 53 mmol/
mol (6.5–7.0%) to avoid complications [26]. Participants
of all ages were included.
4. Studies reporting diabetes-related hospital admissions, e.g.
diabetic ketoacidosis, as either the primary or secondary
outcome were included.
Information sources
Six electronic databases (MEDLINE, PsychINFO, CINAHL,
AMED, Embase and Scopus) were used to identify eligible
studies. Searches were conducted in November 2018 and
updated in February 2019. Citations of studies where full
texts were screened were hand-searched to identify addi-
tional studies and study authors were contacted to request a
copy of full text when not available and to identify any
additional relevant studies. An expert in the field of diabetic
ketoacidosis was contacted to identify further possible
studies. RefWorks was used to organize the results from
each search engine and to remove duplicates.
Search terms
The search strategy was developed using the ’PICO’
(Population, Intervention, Comparison and Outcomes)
approach. Population terms aimed to identify all references
related to individuals with either type 1 or type 2 diabetes
and elevated HbA1c (diabetes or ’diabetes mellitus’ or ’poor
manage* diabetes’ or ’poor glycaemic control’ or diabet* or
diabetic). Intervention search terms related to intervention
delivery and aimed to capture psychosocial interventions
(’psycho* intervention’ or psychother* or intervention* or
’digital intervention’ or telemedicine or ’psychosocial inter-
vention’ or psychoeducation or ’motivation* interview’ or
counselling or ’cognitive behavioural therapy’ or ’group
therapy’ or self-help) and outcome terms related to diabetes-
related hospital admissions (’hospital admission’ or hospi-
talization or ketoacidosis or acidosis or DKA or ’diabetic
ketoacidosis’).
No limitations were applied to databases during the search
to ensure as many eligible studies as possible were identified.
Studies were then excluded according to eligibility criteria
throughout the screening process.
Study selection
On completion of electronic database searches, papers were
exported to RefWorks from all databases. Once duplicates
were removed, an eligibility assessment was performed,
which involved the screening of titles and abstracts against
the inclusion criteria (Appendix S1). Studies that were
retained after screening of titles and abstracts were fully
screened by two independent reviewers (H.M., S.S.) and any
discrepancies were discussed and resolved with a third
independent reviewer (S.C.). The process is summarized in
the PRISMA flow diagram (Fig.1).
Data collection process and data items
Data extraction was undertaken for all studies that met the
inclusion criteria using a structured data extraction form
designed for the review (Appendix S2), adapted from the
Cochrane Collaboration data collection form
(Appendix S3). The data extraction sheet was pilot-tested
on two randomly selected studies and refined accordingly.
Two reviewers (H.M., S.S.) independently extracted data
from each full paper, with any discrepancies resolved by
discussion and consensus. Where information was not
available, study authors were contacted for clarification.
The extracted information captured details on the study
population, intervention and outcomes. Data extracted from
studies using the data extraction form was summarized and
tabulated to identify key characteristics of each study
(Table 1).
Risk of bias
Studies were evaluated using the Effective Public Health
Practice Project Quality Assessment Tool [10] to assess
internal and external validity by rating risk of bias for each
study. Each study was assessed on: selection bias, study
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design, confounders, blinding, data collection methods,
withdrawals and drop-outs, intervention integrity and anal-
yses. Papers were assessed independently by two reviewers
(H.M. and S.S.) and discrepancies were discussed and
resolved by a third reviewer (S.C.). In line with the tool,
studies were rated as having strong, moderate or weak
methodological quality following assessment of bias. The
methodological quality overall and in each domain is
summarized in Table 2 for individual studies and will be
discussed further throughout the review in relation to the
effectiveness of interventions.
Summary measures
The outcome of interest for this systematic review is diabetes-
related hospital admissions. The principal summary measure
used was difference in diabetes-related hospital admissions
before and after the intervention. The time interval between
pre- and post-intervention measures ranged from 5 to 18
months across studies. Odds ratios and confidence intervals
(CIs) are reported with other measures in Table 1, however,
for the purpose of this review only the main outcome will be
discussed in detail.
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Cohen’s d was used to interpret effect sizes of results
reported within the reviewed studies. Effect sizes of 0.20
were considered to be small, while effect sizes of approxi-
mately 0.50 were considered to be medium. Effect sizes of
approximately 0.80 or above were considered to be large
[42].
Synthesis of results
Because there was considerable heterogeneity in study
design, methodology and statistical approaches, a meta-
analysis was not possible. A narrative synthesis was con-
ducted, following the guidance on the conduct of narrative
synthesis in systematic reviews [43].
Results
Study selection
The study selection process and reasons for exclusion were
documented using a PRISMA flow chart (Fig. 1). Character-
istics across studies and interventions are described below,
and the effectiveness of these interventions is summarized,
taking into account methodological quality.
Study characteristics
Table 1 shows the main characteristics of each study
included in the review. Study designs varied and included
two randomized controlled trials (RCTs) [44,45], one non-
RCT [46], and two retrospective analyses of existing data
from a previous RCT [47] and a previous intervention [48].
Across studies, 673 participants were included, with sample
sizes ranging from 22 to 376. Four of the five included
studies had a female sample bias [44,46,47,48], meaning
there was an overall female sample bias across studies. Only
one study included adult participants [47], with the majority
of studies including young people with diabetes. Range and
mean of participant ages could not be calculated because of
missing data. The studies included participants with both
type 1 and type 2 diabetes, although only two included
individuals with type 2 diabetes [47,48]. Ethnicity was only
documented in three of the included studies. In two of these,
white participants accounted for between 64% [47] and
100% [45] of the sample. Ellis et al. [44] reported that 62%
of participants were African American, but no information
on country of origin is stated.
The included studies reported a number of outcomes and
the effectiveness of interventions on these outcomes; how-
ever, as the present review focuses specifically on the impact
on diabetes-related hospital admissions, only the effective-
ness for this outcome is discussed. All studies assessed the
effectiveness of an intervention on diabetes-related hospital
admissions as either a primary or secondary outcome, and
results of individual studies evaluating the effectiveness areTa
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presented in Table 1, with statistics reported to two decimal
places (for full data see original papers cited). Diabetes-
related hospital admissions were recorded and measured
using electronic patient records [44,47,48] and used the
International Classification of Diseases, Ninth Revision –
Clinical Modification codes to capture hospital admissions
specifically related to diabetes. Two of the studies do not
report how diabetes-related hospital admissions were
recorded [45,46].
Intervention characteristics
The rationale for interventions across studies was to improve
outcomes by engaging individuals in diabetes self-manage-
ment. A range of psychosocial interventions was used across
the included studies, including structured education, some
form of psychotherapy and personalised support delivered
via telephone.
Two psychological interventions [44,46] explored the
impact of individual psychotherapy on diabetes-related
hospital admissions. Moran et al. [46] delivered individual
psychotherapy in hospital alongside medical treatment which
involved a detailed formulation of the child’s condition from
a combined endocrinological and psychological viewpoint.
Ellis et al. [44] delivered multisystemic therapy at home to
adolescents and their families, targeting adherence-related
problems.
Two of the interventions included in this review were
telephone-based. Nunn et al. [45] investigated the impact of
bi-monthly telephone calls on diabetes outcomes among
individuals with elevated HbA1c levels. Telephone calls
lasted between 15 and 30 minutes and covered a range of
topics including management advice, psychological support
and education. Parents were also included in discussions if
they usually made the treatment decisions at home. Wagner
et al. [48] explored the effectiveness of a personalized text-
messaging intervention delivered by Novel Interventions In
Children’s Healthcare (NICH) interventionists. Text mes-
sages were personalized and tailored to individual needs,
providing reinforcement for diabetes management, skills
coaching, and assistance with problem-solving.
One study involved a structured education course [47],
which was delivered face to face over a number of weeks in a
classroom setting and delivered by trained coaches who had
received standardized training in diabetes self-management.
Sessions were based on an educational model developed by
Stanford University which focused on equipping individuals
to be proactive in managing their chronic condition, how-
ever, it is not clear from the study what specific topics the
education course covered.
The time interval between measurements of diabetes-
related hospital admissions varied across studies. Pre-inter-
vention measures ranged from 0 to 12 months and follow-up
post-intervention measurements were between 5 and 24
months.
Effectiveness of interventions by intervention type
The effectiveness of these interventions at reducing diabetes-
related hospital admissions among individuals with elevated
HbA1c is presented in Table 1. Of the five interventions
identified, four demonstrated a significant reduction in
diabetes-related hospital admissions [1,29,45].
Results indicated moderate evidence for the effectiveness
of individual psychotherapy at reducing diabetes-related
hospital admissions in individuals with elevated HbA1c
[11,44]. Ellis et al. [44] found that those receiving multisys-
temic therapy had significantly fewer admissions than control
participants, with a medium effect size (P ≤0.05, d = 0.65).
This effect was maintained over the 24-month follow-up
period. Moran et al. [46] also reported a reduction in
hospital admissions related to diabetes among children and
adolescents receiving psychotherapy, with a large effect size
(P ≤0.05, d = 0.83). Both studies had a strong study design
with little bias across domains, however, overall had a
moderate global rating for quality (Table 2), providing
moderate evidence for the effectiveness of interventions
involving individual psychotherapy.
Evidence in support of telephone-based interventions was
weak. Wagner et al. [48] reported a significant decrease in
the number of ketoacidosis episodes as a result of a text-
messaging intervention (P ≤0.01, d = 0.56), despite no
significant difference in emergency department visits (P =
0.57, d = 0.17). However, this was a retrospective study
design with a small sample and data were only for individ-
uals with available text message data meeting criteria so may
not be generalizable to other populations. There was also a
risk of confounders and blinding bias, therefore, evidence to
support the effectiveness of text-messaging interventions at
reducing diabetes-related hospital admissions is weak. Fur-
thermore, there was strong evidence to suggest bi-monthly
telephone calls are ineffective at reducing diabetes-related
hospital admissions among individuals with elevated HbA1c.
Nunn et al. [45] reported an increase in admissions in both
intervention and control groups with a small effect size (P =
0.57, d = 0.31).
Adepoju et al. [47] reported that individuals in the
intervention group receiving structured education on dia-
betes management had significantly lower odds of healthcare
utilization (P ≤0.05) when compared to participants in other
arms, however, the methodological quality was poor because
of a lack of clarity on data collection methods and measures
and risk of confounder, blinding and withdrawal bias.
Despite statistically significant results, therefore, we cannot
confidently draw conclusions regarding the effectiveness of
this intervention.
Methodological quality
The methodological quality of the included studies was
assessed using the Effective Public Health Practice Project
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Quality Assessment Tool [41] for quality assessment and is
summarized in Table 2.
Selection bias across studies was generally low, therefore,
studies were likely to be representative of the target popu-
lation, and study design was also rated as strong, with the
exception of one retrospective analysis [48]. In most cases,
data collection tools were shown to be valid and reliable
[44,45,46,48], however, it was unclear in one study [47] as
data collection methods and measures used were not stated.
It was clear in three studies that there were no important
differences between groups prior to the intervention
[44,45,46], however, in the remaining studies there is a risk
of bias as both differences between groups, and whether
confounders were controlled if differences were present were
unclear. There was also a risk of blinding bias across studies
as two studies reported that outcome assessors were aware of
the intervention or exposure status of participants [45,46],
and blinding status in the remaining studies was unclear.
Three studies [44,45,48] reported withdrawals and drop-
outs in terms of numbers and the reasons. For the remaining
two studies withdrawals and reasons were not reported,
therefore, there is a risk of bias across studies when
considering withdrawals and drop-outs.
Overall, the risk of bias across studies was moderate. The
main methodological flaw was risk of bias because of a lack
of blinding or not enough information about blinding in
individual studies. None of the included studies received a
‘strong’ rating for blinding (Table 2) and this has an impact
on the conclusions that can be drawn from the results of the
present review.
Discussion
The aim of the present systematic review was to explore the
effectiveness of psychosocial interventions on diabetes-re-
lated hospital admissions among individuals with elevated
HbA1c. To our knowledge this is the first study to address
what might work better in this higher-risk group in relation
to reducing the burden on healthcare. Results from this
systematic review provide moderate evidence for the effec-
tiveness of psychosocial interventions at reducing diabetes-
related hospital admissions in the high-risk population. Five
quantitative studies met the inclusion criteria and four of
these reported significant improvements in hospital admis-
sions related to diabetes, with effect sizes ranging from small
to large and mixed methodological quality.
Results provided moderate evidence to support the effec-
tiveness of interventions involving individual psychotherapy
to reduce diabetes-related hospital admissions among ado-
lescents with elevated HbA1c with medium to large effect
sizes [44,46]. Interventions delivering individual psychother-
apy [44,46] should be considered for such individuals to
reduce the risk of complications and hospital admissions
related to diabetes. Such interventions are costly as they
involve intensive interventions and therapists have small
caseloads, however, Ellis et al. [44] reported that whilst
providing multisystemic therapy was costly (£5,380 per
youth), there was still a substantial cost offset due to
reductions in diabetic ketoacidosis admissions, therefore,
there is the potential for overall savings despite initial costs
incurred.
The effectiveness of other interventions included in this
review is less clear. Text-messaging-based interventions and
structured education programmes targeted at individuals
with elevated HbA1c levels do have potential to reduce
diabetes-related hospital admissions and as these interven-
tions are less resource-intensive, they are likely to be more
cost-effective [47,48]. Adepoju et al. [47] found that partic-
ipants receiving the self-management programme had signif-
icantly lower odds of diabetes-related hospital admissions,
which supports previous research [49], however, due to
methodological flaws the generalizability of results cannot be
guaranteed, and further research with strong methodological
quality is needed.
Support for the effectiveness of telephone-based interven-
tions was also inconclusive. A personalized text-messaging
intervention with tailored messages providing reinforcement,
skills coaching and problem-solving was reported to signif-
icantly reduce diabetic ketoacidosis episodes and hospital-
ization with a medium effect size [48], however, this was a
retrospective analysis and due to underpowered analyses and
lack of a control group it is not possible to determine the
effectiveness of text-messaging-based interventions on reduc-
ing diabetes-related hospital admissions. Furthermore, there
Table 2 Risk of bias according to Effective Public Health Practice Project Quality Assessment Tool (1998)
Author
Selection
bias
rating
Study design
rating
Confounders
rating
Blinding
rating
Data
collection
method
rating
Withdrawals
and drop-outs
rating
Global
rating
Adepoju et al. (2014) [48] Strong Strong Moderate Weak Weak Weak Weak
Ellis et al. (2005) [44] Moderate Strong Strong Weak Strong Strong Moderate
Wagner et al. (2017) [47] Strong Weak Weak Weak Strong Strong Weak
Moran et al. (1991) [46] Strong Strong Strong Weak Strong Moderate Moderate
Nunn et al. (2006) [45] Strong Strong Strong Moderate Strong Strong Strong
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was strong evidence to suggest that bi-monthly telephone
calls offering management advice, psychological support and
education does not improve the rate of diabetes-related
hospital admissions [45], therefore, more research is needed
to determine the effectiveness of telephone-based interven-
tions in this population.
Recommendations drawn from this review must consider
the scientific quality of methods used in the field as
methodological flaws were identified in the design of many
studies included in this review (Table 2). The most common
methodological flaw was found to be issues with blinding,
however, there were methodological weaknesses identified in
all studies therefore further research is needed in this area to
improve knowledge and understanding of the effectiveness of
psychosocial interventions at reducing diabetes-related hos-
pital admissions in individuals with elevated HbA1c.
Limitations at review level should also be acknowledged.
Because of the specific focus on diabetes-related hospital
admissions as an outcome, only five studies met the inclusion
criteria (Figure 1), therefore, the sample of studies reviewed
was small and further research is needed. This was consid-
ered as a potential issue when defining the search terms, and
a broad study population including all ages and individuals
diagnosed with both type 1 and type 2 diabetes was chosen,
with the aim of capturing as many relevant studies as
possible to assess the effectiveness of current interventions.
As this research reviewed interventions aimed at both type
1 and type 2 diabetes, it is important to consider that
intervention needs are likely to differ because of differences
in the aetiology of disease, and in the management and
psychological needs of people living with the conditions.
Such differences must be considered when designing inter-
ventions to reduce diabetes-related hospital admissions in
order to address specific needs relevant to type 1 or type 2
diabetes.
Furthermore, there is a lack of explicit theoretical rationale
for interventions included in this review, which is important
to consider as previous research suggests theoretically based
interventions may be more beneficial [36].
Despite the small number of final papers included, focusing
on diabetes related hospital admissions as an outcome was
required for the purpose of this review; however, further
research is required in order to draw significant conclusions.
Results from this study may also be subject to publication
bias as, although reference lists were hand-searched, there
was no extensive review of grey literature. Potential papers
may also have been missed as a result of excluding papers
that were not published in the English language.
Only one of the five included studies [47] included adults
in the study sample, therefore, results cannot be generalized
to the general population of individuals with elevated HbA1c
values. Most studies only included participants with type 1
diabetes, therefore, results are unlikely to be applicable to
individuals with type 2 diabetes. Future research should
therefore target adults diagnosed with type 2 diabetes and
are identified as having elevated HbA1c.
The majority of individuals living with diabetes are
diagnosed with type 2 diabetes and are adults [1], therefore,
without addressing this key population gap the ability to
draw conclusions from research regarding the effectiveness of
interventions is limited.
Furthermore, whilst all the studies were conducted in
western countries (UK, USA and Australia), only one of the
studies included in this review was conducted in the UK,
therefore, generalisability to the UK population and health-
care system should be considered and further research
conducted in the UK is needed.
In conclusion, this systematic review provides an evalua-
tion of current intervention research in this area and has
identified four psychosocial interventions that have reduced
diabetes-related hospital admissions among individuals with
elevated HbA1c. In particular, there is good evidence that
interventions involving psychotherapy for the high-risk
population have the potential to reduce the risk of compli-
cations, hospital admissions and related costs. Designing and
testing psychosocial interventions targeting individuals with
elevated HbA1c should be considered, but the results of this
review indicate the need for further research with method-
ological rigour to build on existing evidence.
As found previously [36], this review highlights the need
for psychosocial interventions to be guided by principles of
psychological theory.
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